ADJUVANT THERAPY FOR HIGH RISK PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER FOLLOWING RADICAL CYSTECTOMY

Gehan Ibrahim Abd el Lateef El Sharaany;

Abstract


Bladder cancer is the most common malignancy among males in Egypt. Its relative frequency ranged between 10-33% in different hospitals based cancer registries.
In population based cancer registries performed in Gharbia governorate, Egypt, it was estima


Other data

Title ADJUVANT THERAPY FOR HIGH RISK PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER FOLLOWING RADICAL CYSTECTOMY
Other Titles دور العلاج المساعد فى مرضى سرطان الخلايا الانتقالية للمثانة ما بعد الاستئصالالجذرى للمثانة
Authors Gehan Ibrahim Abd el Lateef El Sharaany
Keywords ADJUVANT THERAPY FOR HIGH RISK PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER FOLLOWING RADICAL CYSTECTOMY
Issue Date 2007
Description 
Bladder cancer is the most common malignancy among males in Egypt. Its relative frequency ranged between 10-33% in different hospitals based cancer registries.
In population based cancer registries performed in Gharbia governorate, Egypt, it was estima

Attached Files

File SizeFormat
123092m3209.pdf100.07 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.